Introduction
Gene therapy, in theory, could embrace a wide range of strategies for the permanent or transient alleviation of any of a great variety of diseases including cancer. Retroviral vectors are by far the most frequently used system in clinical trials. No serious side-effects have been reported so far in clinical gene therapy trials using retroviral systems. There is no evidence to suggest that contamination of wild-type replication-competent retroviruses has occurred in clinical trial materials. Importantly, although the numbers are to date, still small, there is no evidence to support one of the initial concerns of this vector delivery system, that is, the potential for insertional mutagenesis. 1 Some positive attributes of the retroviral system are that the vectors have sufficient coding capacity for most therapeutic genes, they are relatively easy to produce, therapeutic levels of gene expression for a variety of genes have been obtained, and importantly, expression of the transduced gene is stable.
Although the target diseases of gene therapy include cancer, infectious diseases, monogenic inherited dis-orders and other diseases, the greatest number of protocols are targeted at the treatment of various types of cancer. One of the most promising approaches for gene therapy against cancer is the use of suicide genes which render transduced tumor cells sensitive to normally nontoxic prodrugs. 2, 3 The herpes simplex virus thymidine kinase (HSVtk) gene is a prototypic suicide gene, because it can effectively phosphorylate an antiviral nucleoside analogue, ganciclovir (GCV), to its monophosphate form, which is further phosphorylated by cellular kinases to DNA polymerase inhibitors. 4 Because GCV is a relatively poor substrate for mammalian thymidine kinases, concentrations can be achieved that are lethal to cells expressing the HSVtk gene but are nontoxic to normal mammalian cells. An attractive feature observed in both in vitro and in vivo experiments is that HSVtk-transduced cells treated with GCV were lethal to neighboring HSVtkuntransduced cells. This unexpected phenomenon, termed the 'bystander effect', is extremely important in achieving effective therapeutic responses against cancer, because it appears impossible to introduce a suicide gene into all the cells of a cancer by currently available gene transfer techniques. Effectiveness of the HSVtk/GCV system for the treatment of cancer has been demonstrated in animal models carrying various types of cancer, and several gene transfer protocols using this system have progressed into human clinical trials for the treatment of cancer. 5 It has been observed that exogenously introduced genes are inactivated in vivo, and it has been suggested that this inactivation involves de novo methylation. 6 Adenoviruses 7,8 and retroviruses 9, 10 have been shown to undergo de novo methylation in vivo. Although it is not clear whether or not de novo methylation is the primary inactivating event, 11, 12 it is possible that de novo methylation stabilizes the repressed state. The repression of retroviral vectors is specifically frustrating, because expression of retrovirally transduced genes are expected to be stable. Inhibition of retroviral long terminal repeat (LTR) promoter-driven exogenous genes has been observed in primary fibroblast 13 and hematopoietic cells.
14, 15 However, there have been several reports indicating that retroviral transgenes are appropriately expressed when the genes are under the control of internal promoters. [16] [17] [18] [19] It, therefore, seemed reasonable to use an internal promoter to direct therapeutic gene expression in retrovirus-mediated gene therapy experiments.
We have previously demonstrated that transduction of the HSVtk gene under the transcriptional control of the albumin gene promoter or myelin basic protein gene promoter could render solely hepatocellular carcinoma (HCC) cells or glioma cells susceptible to GCV toxicity without affecting other types of cells, 20, 21 and that HSVtktransduced tumor cells could induce substantial killing of neighboring untransduced wild-type tumor cells. 22 Furthermore, considerably large-sized HSVtk-transduced tumors responded to GCV treatment, resulting in complete tumor regression in 11 of 14 mice. In the remaining three animals, however, tumors did not regress completely despite GCV treatment. 23 In the present study, we established three cell lines that were refractory to GCV treatment in the above-mentioned experiment. We report here that these GCV-refractory clones are resistant to GCV treatment due to methylation of the transduced HSVtk gene under the control of the internal albumin gene promoter but not due to deletion of the gene. Furthermore, demethylation of GCV-refractory lines upon treatment with 5-azacytidine results in increased sensitivity to GCV. These observations indicate that inhibition of foreign gene expression by methylation has important therapeutic and pharmacological implications, and inhibition of methylation of exogenous sequences may enhance significantly effects of gene therapy.
Results
Establishment of GCV-refractory cells BNL1ME A.7R.1 murine HCC cells, originally established from a BALB/c mouse, were infected with Alb e/ppNT230 retroviruses which carry the HSVtk gene under the transcriptional control of the albumin gene promoter and the neomycin phosphotransferase gene directed by the Moloney murine leukemia virus LTR promoter ( Figure 1 ). Retrovirus-infected cells were selected by addition of G418 in media. The bulk of uncloned G418-resistant HCC cells were expanded and used as HSVtktransduced HCC cells. Fourteen syngeneic BALB/c mice were inoculated subcutaneously with HSVtk-transduced HCC cells. When the tumor reached approximately 20 mm at its largest diameter, the animals were treated with intraperitoneal injections of GCV (50 mg/kg body weight per day) for 14 consecutive days. Eleven of 14 mice exhibited complete tumor regression by 12 days after initiation of the GCV treatment. In the remaining three mice, however, tumors were not eradicated completely by the GCV treatment. 23 After the treatment, these three tumors were excised from animals, mashed through a strainer, and suspended in appropriate amounts of the conditioned medium. After the suspensions stood for 5 min to precipitate the remaining debris, supernatants were collected and cultured in an atmosphere of 37°C and 5% CO 2 . After passaging cells for 1 month, they were confirmed to be HCC cells without contamination of other types of adherent cells such as fibroblasts and macrophages, by their morphological appearances. Thus three GCV-refractory cell lines were established from three HCC tumors, and designated as GCV-refractory ␣, ␤ and ␥ cells.
Proliferation activity of GCV-refractory cells
We first examined proliferation activity of GCV-refractory cell lines because they appeared to be somewhat slow in growth during culture for their establishment. GCV-refractory cells, parental cells and HSVtk-transduced cells were seeded at a density of 1 × 10 3 cells/cm 2 in the conditioned medium, and the number of live cells was determined after trypan blue staining. GCV-refractory ␤ and ␥ cells exhibited delayed growth ratios as compared with parental cells. The mean doubling time of GCV-refractory ␤ and ␥ cells was 21.3 and 22.4 h, respectively, while that of parental and HSVtk-transduced cells was 15.4 and 16.6 h, respectively. Generation time of GCV-refractory ␤ and ␥ cells was significantly longer than that of parental and HSVtk-transduced cells.
On the other hand, the mean doubling time of GCVrefractory ␣ cells was 16.1 h and their generation time was not significantly different from that of parental cells.
Sensitivity of GCV-refractory cells to GCV
Sensitivity of GCV-refractory cells, parental cells and HSVtk-transduced cells was examined. As shown in Figure 2 , HSVtk-transduced cells were susceptible to GCV in a dose-dependent manner and were completely eliminated at a GCV concentration of 5 m. The value of IC 50 , defined as the dose required for 50% cytotoxicity, was approximately 50 nm. In contrast, GCV-refractory cells were substantially resistant to GCV and there were no significant differences in GCV sensitivity between GCV-refractory lines and parental cells. IC 50 values of GCV-refractory ␣, ␤ and ␥ cells and parental cells were approximately 100 m.
Figure 2 Sensitivity of GCV-refractory cells to GCV. GCV-refractory ␣ (᭹), ␤ (í) and ␥ (᭡) cells, as well as their parental (᭺) and

Sensitivity of GCV-refractory cells to G418
Because GCV-refractory cells had been simultaneously transduced with the neomycin phosphotransferase gene by the retroviral construct, we then examined if GCVrefractory lines were still resistant to G418. As shown in Figure 3 , HSVtk-transduced cells were substantially resistant to G418 and a G418 concentration of 500 g/ml did not produce a significant impact on cell survival. Conversely, all GCV-refractory lines were susceptible to G418 toxicity in a dose-dependent manner and there were no significant differences in G418 sensitivity between GCV-refractory lines and parental cells.
Figure 3 Sensitivity of GCV-refractory cells to G418. GCV-refractory ␣ (᭹), ␤ (í) and ␥ (᭡) cells, as well as their parental (᭺) and
Southern blot analysis of the HSVtk gene
Because GCV-refractory lines were shown to be resistant to GCV and sensitive to G418, deletion of the retrovirally transduced genes was first considered. To confirm this, genomic DNA was extracted from GCV-refractory lines, digested with BglII, and analyzed by Southern blot using a 1.9-kb HSVtk probe (see Materials and methods). As shown in Figure 4 , all GCV-refractory lines as well as HSVtk-transduced cells were shown to possess the HSVtk gene. Subsequent Southern blot analysis revealed that the neomycin phosphotransferase gene was also not deleted from the genome of GCV-refractory lines (data not shown).
Methylation analysis of the HSVtk gene
To learn about the mechanism of the loss of transduced gene expression, we then examined if the HSVtk gene was methylated. There is a unique SmaI site in the HSVtk gene and this methylation-sensitive restriction enzyme was utilized to examine the methylation state of the gene. Genomic DNA isolated from HSVtk-transduced cells and GCV-refractory cells was digested by BglII and then SmaI, and Southern blot analysis was performed using a 1.9-kb HSVtk probe. As shown in Figure 5 , a 1.9-kb fragment of the HSVtk gene isolated from HSVtk-transduced cells was completely digested by SmaI, resulting in 1.2-kb and 0.7-kb fragments. Conversely, the HSVtk gene isolated from GCV-refractory cells was resistant to methylation-sensitive SmaI digestion. There were 1.9-kb, 1.2-kb and 0.7-kb fragments in the GCV-refractory ␣ sample, and only a 1.9-kb fragment in the GCV-refractory ␤ and ␥ samples, indicating that retrovirally transduced HSVtk gene was heavily methylated in GCV-refractory ␣ cells and completely methylated in GCV-refractory ␤ and ␥ cells. GCV sensitivity of GCV-refractory cells after 5-azacytidine treatment To examine whether the treatment with 5-azacytidine, a drug that reduces the level of DNA methylation in mammalian cells, 24 can render GCV-refractory cells sensitive to GCV, GCV-refractory cells, parental cells and HSVtktransduced cells were cultured with freshly prepared 5 m 5-azacytidine for 48 h and the medium was changed to a new one containing various concentrations of GCV. After a 3-day incubation, cell viability was assessed by the MTT assay. As shown in Figure 6 , sensitivity of GCVrefractory cells to GCV was partially restored, and viability of GCV-refractory ␣, ␤ and ␥ cells was signifi-
Figure 6 Sensitivity of GCV-refractory cells to GCV after 5-azacytidine treatment. GCV-refractory ␣ (᭹), ␤ (í) and ␥ (̆) cells, as well as their parental (᭺) and HSVtk-transduced () cells, were treated with freshly prepared 5 m 5-azacytidine for 48 h, and then cultured with various concentrations of GCV for 3 days. Viable cell number was assessed by the MTT assay. Each data point represents the mean ± s.d. of four separate experiments. The symbol '*' represents that values of GCV-refractory ␣, ␤ and ␥ cells are significantly different from that of parental cells at P Ͻ 0.01 by Student's t test.
cantly decreased as compared with that of parental cells at GCV concentrations of у2 m.
G418 sensitivity of GCV-refractory cells after 5-azacytidine treatment
To examine whether the treatment with 5-azacytidine can restore the G418 resistance of GCV-refractory cells, GCVrefractory cells, parental cells and HSVtk-transduced cells were cultured with freshly prepared 5 m 5-azacytidine for 4 days and the medium was changed to a new one containing various concentrations of G418. After a 7-day incubation, cell viability was assessed by the MTT assay. As shown in Figure 7 , resistance of GCV-refractory cells to G418 was partially restored, and viability of GCVrefractory ␣, ␤ and ␥ cells was significantly higher as compared with that of parental cells at all the G418 concentrations tested.
Discussion
In this article, we demonstrate that expression of the retrovirally transduced HSVtk gene under the transcriptional control of the albumin gene promoter in HCC cells was not stable in vivo and could not be restored in cells recultivated from the grafts. The HSVtk gene was not deleted from the genome of GCV-refractory cells, but extensively or completely methylated. It is also shown that 5-azacytidine treatment can partially restore the sensitivity of GCV-refractory cells to GCV. These results indicate that expression of retrovirally transduced gene may not persist in vivo due to methylation even when the gene is directed by an internal housekeeping gene promoter.
One of the therapeutic challenges to various diseases in the next decade will be to utilize the potential of gene therapy. An important delivery concept that is currently used in various gene therapy experiments is the utiliz- ation of viral vectors. However, exogenous genes transduced with viral vectors have been shown to be inactivated in vivo, and it has been suggested that this inactivation involves de novo methylation of transcriptionally regulatory sequences or coding sequences. Doerfler 25 has suggested that de novo methylation might act as a general mechanism of inactivation of exogenous DNA and protection of vertebrate genomes against intrusion by foreign genetic materials. It has been shown that methylation of specific sites in adenoviral promoter sequences results in inactivation of these promoters. 26 It has also been shown that expression from a herpes virus promoter is inhibited by methylation. 27, 28 Similarly, inhibition of the expression of exogenous genes driven by a retroviral LTR promoter has been observed in primary fibroblast 13 and hematopoietic cells. 14, 15 De novo methylation of an introduced gene itself was also observed in transgenic mice. 29, 30 Repression of retroviral vectors is especially frustrating because retroviral systems possess some positive attributes. First, retroviruses only infect dividing cells, 31 making them more suitable than other recombinant viruses such as adenoviruses, adeno-associated viruses and herpes simplex viruses, for selective transduction of tumor cells, because most normal cells surrounding cancers are in a quiescent, nonreceptive stage of cell growth. Second, since retroviruses integrate in the genome of replicating cells, expression of transduced genes is expected to persist for a long period, indicating that retrovirus-mediated gene transfer is suitable for genetic correction of genetic disorders. Therefore, repression of retrovirally transduced foreign genes by methylation has important therapeutic and pharmacological implications.
Figure 7 Sensitivity of GCV-refractory cells to G418 after 5-azacytidine treatment. GCV-refractory ␣ (᭹), ␤ (í) and ␥ (̆) cells, as well as their parental (᭺) and HSVtk-transduced () cells
Scharfmann et al 32 demonstrated that long-term expression of retrovirally transduced foreign genes in mouse embryo fibroblast implants can be achieved if a housekeeping gene promoter, but not the cytomegalovirus immediate-early region promoter, is employed to drive transcription. It has been reported in transgenic mouse experiments that some transgenes with retroviral elements have been poorly expressed and heavily methylated. 9, 33 However, there are several reports indicating that retroviral transgenes have been appropriately expressed when assessing genes that are expressed from internal promoters. [16] [17] [18] Furthermore, it has been observed that internal promoters may be active even if expression from the retroviral LTR promoter is silent. 19, 34 It has also been demonstrated that the use of internal promoters derived from housekeeping genes such as phosphoglycerate kinase or ␤-actin, instead of the retroviral LTR promoter, may overcome the repression of retrovirally transduced genes. 35, 36 We have demonstrated that the albumin gene promoter can induce much stronger expression of cytokine genes such as interleukin-2, interleukin-3 and tumor necrosis factor-␣ genes in HCC cells not only in ex vivo gene transfer but also in in vivo gene transfer as compared with the simian virus 40 early region promoter which is recognized as a generally strong promoter. 37, 38 Taken collectively, the use of internal promoters derived from housekeeping genes instead of the retroviral LTR promoter is considered to be useful in overcoming inhibition of exogenous gene expression and in inducing strong and long-lasting exogenous gene expression.
We, therefore, produced a retrovirus construct carrying the HSVtk gene under the transcriptional control of the housekeeping albumin gene promoter and transduced the HSVtk gene into HCC cells. Expression of the HSVtk gene, however, was not stable in vivo and the gene was shown to be extensively or completely methylated. 5-Azacytidine treatment partially restored the sensitivity of GCV-refractory cells to GCV. Inhibition of the HSVtk gene expression was not seen during long-term culture of the cells in vitro, probably because of the existence of G418 contained in the conditioned medium. These results indicate that methylation of retrovirally transduced genes may be caused in vivo even when the genes are directed by an internal housekeeping gene promoter in retroviral vectors. Furthermore, resistance of GCV-refractory cells to G418 was also partially restored by 5-azacytidine treatment. Although we did not examine whether the neomycin phosphotransferase gene was methylated, these results suggested that the neomycin phosphotransferase gene under the transcriptional control of the LTR promoter was also methylated.
A potential approach to overcome repression of retrovirally transduced genes is the use of inhibitors of DNA methyltransferase such as 5-azacytidine and 5-deoxyazacytidine to demethylate and activate the repressed genes. Jaenisch et al 39 and Araki et al 30 demonstrated that injection of 5-azacytidine can be used effectively and reproducibly to activate silent transgenes in transgenic mice. 5-Azacytidine and 5-deoxyazacytidine are phosphorylated by cellular kinases, incorporated into DNA, and trap DNA methyltransferase molecules by forming a covalent bond with the catalytic site of the protein. This mechanism of action, although efficient in inhibiting DNA methylation, results in potential side-effects that limit the utility of 5-azacytidine and 5-deoxyazacytidine as therapeutic agents, as well as research tools. Although new demethylating agents which can be safely employed in clinical treatment need to be developed, the results demonstrated in the present study indicate that treatment with demethylating agents might be used efficiently and reproducibly to activate repressed transduced gene, resulting in long-lasting therapeutic benefits. These observations may also have important implications for clinical applications of retrovirus-mediated gene transfer into target cells, where persistent gene expression would be needed for an enduring therapeutic effect.
Materials and methods
Chemicals and animals GCV sodium (GCV) was generously provided by F Hoffmann-La Roche (Basel, Switzerland). Geneticin (G418) was purchased from GIBCO-BRL (Bethesda, MD, USA). 5-Azacytidine was obtained from Sigma (St Louis, MO, USA). Eight-week-old female BALB/c mice were purchased from Japan SLC (Hamamatsu, Japan). Animal experiments were performed with approved protocols and in accordance with recommendations for proper care and use of laboratory animals.
Cell culture
The murine HCC cell line, BNL1ME A.7R.1, which was originally established from a BALB/c mouse, and amphotropic retrovirus packaging cell line, PA317, were purchased from the American Type Culture Collection (Rockville, MD, USA). Cells were cultured in RPMI 1640 medium supplemented with 10% (v/v) heat-inactivated fetal calf serum, 0.3 mg/ml l-glutamine, 100 U/ml ampicillin and 100 g/ml streptomycin at 37°C in 5% CO 2 in air.
Retroviral vector
Construction of the Alb e/p-pNT230 retroviral vector, which contains the HSVtk gene under the transcriptional control of the murine albumin gene enhancer and promoter, has been described previously, 40 and a diagram is shown in Figure 1 . The vector contains eukaryotic expression elements: (5′) Moloney murine leukemia virus LTR, neomycin phosphotransferase gene as a dominantpositive selectable marker conferring resistance to the neomycin analogue G418, murine albumin gene enhancer and promoter region 41 as an internal promoter, HSVtk gene 42 as a gene of interest, and Moloney murine leukemia virus LTR (3′). In this vector, expression of the HSVtk gene is expected to be directed by the albumin gene enhancer and promoter element. The HSVtk gene can be excised out by BglII digestion, because two BglII sites are located at the 5′ and 3′ ends of the gene, resulting in release of a 1.9-kb fragment of the HSVtk gene. There is a unique methylation-sensitive SmaI site in the HSVtk gene and SmaI digestion divides the gene into approximately 0.7-and 1.2-kb fragments.
Gene transfer
Recombinant retroviruses were generated from the above-mentioned retroviral vector by transient transfection of PA317 amphotropic retroviral packaging cells, and cells were infected with the viruses as described previously. 37 Cells were exposed to viruses supplemented with 8 g/ml polybrene overnight and then cultured for 2 days in the fresh medium. Cells were then grown in the medium containing 1 mg/ml G418. The bulk of uncloned G418-resistant cells were expanded and used as HSVtktransduced ones for subsequent experiments.
GCV sensitivity
Cells were plated at a density of 1 × 10 3 cells/cm 2 with various concentrations (0.1-200 m) of GCV. After incubation for 3 days, sensitivity to GCV was evaluated by using an MTT tetrazolium conversion assay, as described previously. 22 The number of viable cells was calculated using curve-fitting parameters based on the Marquardt method. 43 The viability of cells was determined by comparing the number of viable cells with and without GCV.
G418 sensitivity
Cells were plated at a density of 1 × 10 3 cells/cm 2 with various concentrations (1-500 mg/ml) of G418. The viable cell number was assessed by the MTT assay. The viability of cells was determined by comparing the number of viable cells with and without G418.
DNA analysis
Genomic DNA was extracted from cell pellets for Southern blot analysis. DNA was isolated by sodium dodecyl sulfate-proteinase K and RNase digestion at 55°C for 4 h. The digested samples were extracted with phenol-chloroform; the DNA was precipitated in ethanol and resuspended in Tris-EDTA buffer. 44 Genomic DNA samples (10 g) were digested with the restriction enzyme BglII (Takara, Kusatsu, Japan), which cuts both ends of the HSVtk gene in the Alb e/p-pNT230 retroviral construct and releases a 1.9-kb HSVtk fragment. The digested DNA was electrophoresed on a 0.7% agarose gel, denatured and blotted on to a nylon membrane. Then, the filter was probed with the 32 P-labeled 1.9-kb HSVtk fragment, washed, and autoradiographed.
Methylation analysis
Genomic DNA (15 g) was digested with the restriction enzyme BglII and then with methylation-sensitive SmaI (Takara). BglII-SmaI-digested genomic DNA was electrophoresed on a 0.7% agarose gel, denatured and blotted on to a nylon membrane. Blots were hybridized with a 32 P-labeled 1.9-kb HSVtk probe, washed and autoradiographed.
Statistics
Results are expressed as means ± s.d. The Student's t test was used and P values of Ͻ0.05 were considered to indicate significant differences between groups.
